Source: Annual Congress 2001 - Emerging developments in lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hofer, W. Bossart, R. Naef, R. Speich, E. W. Russi, A. Boehler (Zurich, Switzerland). Influenza vaccination after lung transplantation: does nasal application improve immunological response?. Eur Respir J 2001; 16: Suppl. 31, 1271

Member's Comments

No comment yet.

Related content which might interest you: The humoral immune response to influenza vaccination in lung transplant patients Source: Eur Respir J 2001; 18: 971-976 Year: 2001 Is influenza trivalent vaccination effective in lung transplant recipients? Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018 Is the timing of BCG administration important in the immunemodulation of lung allergic response? Source: Annual Congress 2004 - Modulation of the allergic response in animal models Year: 2004 Do different vaccination regimens for BCG and hepatitis B affect the development of allergic disorders in early childhood? Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Influenza virus-induced lung injury: pathogenesis and implications for treatment Source: Eur Respir J 2015; 45: 1463-1478 Year: 2015 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Panel discussion: COVID-19 and lung transplantation: how to handle? Source: ERS webinar 2022 Access for REGISTERED non-members Year: 2022 Lung transplantation and emerging fungal infections: another challenge for late survival Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006 Oral presentation: The long-term effect of neonatal respiratory syncytial virus (RSV) infection on the response to adult allergen challenge Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010 Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Viral infection land lung function decline following lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Influenza surveillance and vaccination: new developments Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 Seasonality in airway pathogens during the first year after lung transplantation: A single center experience Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Novel intradermal influenza vaccine: phase 3 data in targeted adult populations Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008 Compromised immunity and the microbiome: transplantation, cancer and HIV Source: Eur Respir Monogr 2019; 83: 195-215 Year: 2019 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Development of RSV vaccines: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019 Pneumococcal vaccination in bronchiectasis- an area for improvement? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Influenza vaccination in chronic asthma patients. Are more severely ill patients more likely to seek vaccination? Source: Annual Congress 2013 –Viral infections Year: 2013